| [1] |
Pryce J, Kiho L, Scheimberg I. Sudden unexpected death in infancy associated with an epithelial-type hepatoblastoma in a 6-month-old infant[J]. Pediatr Dev Pathol, 2010, 13(4): 338-340.DOI: 10.2350/09-07-0687-CR.1.
|
| [2] |
Turcotte LM, Georgieff MK, Ross JA, et al. Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology Group[J]. Pediatr Blood Cancer, 2014, 61(11): 2018-2023.DOI: 10.1002/pbc.25128.
|
| [3] |
Kehm RD, Osypuk TL, Poynter JN, et al. Do pregnancy characteristics contribute to rising childhood cancer incidence rates in the United States?[J]. Pediatr Blood Cancer, 2018, 65(3): 10.1002/pbc.26888.DOI: 10.1002/pbc.26888.
|
| [4] |
Heck JE, Meyers TJ, Lombardi C, et al. Case-control study of birth characteristics and the risk of hepatoblastoma[J]. Cancer Epidemiol, 2013, 37(4): 390-395.DOI: 10.1016/j.canep.2013.03.004.
|
| [5] |
Chatterejee P, Subramanian H, Panneerselvam S. Anesthetic approach to a case of hepatoblastoma with right atrial spread for simultaneous resection of both[J]. Cureus, 2022, 14(6): e25796.DOI: 10.7759/cureus.25796.
|
| [6] |
Uchida H, Sakamoto S, Komine R, et al. Strategy for hepatoblastoma with major vascular involvement: a guide for surgical decision-making[J]. Surgery, 2023, 173(2): 457-463.DOI: 10.1016/j.surg.2022.11.002.
|
| [7] |
Pepelassis D, Leaker M, Sequeira IB. Right atrial invasion by hepatic tumour[J]. Cardiol Young, 2007, 17(6): 688.DOI: 10.1017/S1047951107001394.
|
| [8] |
Sayed S, Prabhu S, Fawcett J, et al. A systematic surgical approach to hepatoblastoma with intracardiac extension[J]. Asian Cardiovasc Thorac Ann, 2017, 25(4): 300-303.DOI: 10.1177/0218492317705565.
|
| [9] |
|
| [10] |
Un J, Jeong K. Recent updates on the classification of hepatoblastoma according to the International Pediatric Liver Tumors Consensus[J]. J Liver Cancer, 2022, 22(1): 23-29.DOI: 10.17998/jlc.2022.02.24.
|
| [11] |
Hou JY, Yeh TC, Huang TH, et al. A retrospective study of clinical features and outcome in patients with refractory or recurrent hepatoblastoma: a single institution experience[J]. Pediatr Neonatol, 2021, 62(4): 400-405.DOI: 10.1016/j.pedneo.2021.03.018.
|
| [12] |
Cairo S, Armengol C, Maibach R, et al. A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients[J]. Eur J Cancer, 2020, 141: 30-39.DOI: 10.1016/j.ejca.2020.09.026.
|
| [13] |
|
| [14] |
|
| [15] |
Espinoza AF, Patel RH, Patel KR, et al. A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma[J]. J Hepatol, 2024, 80(4): 610-621.DOI: 10.1016/j.jhep.2024.01.003.
|
| [16] |
|
| [17] |
Bera G, Das RN, Roy P, et al. Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas[J]. Pediatr Surg Int, 2017, 33(9): 961-970.DOI: 10.1007/s00383-017-4115-2.
|
| [18] |
|
| [19] |
Venkatramani R, Stein JE, Sapra A, et al. Effect of neoadjuvant chemotherapy on resectability of stage Ⅲ and Ⅳ hepatoblastoma[J]. Br J Surg, 2015, 102(1): 108-113.DOI: 10.1002/bjs.9681.
|
| [20] |
Sakamoto S, Kasahara M, Mizuta K, et al. Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan[J]. Liver Transpl, 2014, 20(3): 333-346.DOI: 10.1002/lt.23803.
|
| [21] |
Faraj W, Dar F, Marangoni G, et al. Liver transplantation for hepatoblastoma[J]. Liver Transpl, 2008, 14(11): 1614-1619.DOI: 10.1002/lt.21586.
|
| [22] |
Kerkar N, Lakhole A. Pediatric liver transplantation: a North American perspective[J]. Expert Rev Gastroenterol Hepatol, 2016, 10(8): 949-959.DOI: 10.1586/17474124.2016.1166951.
|
| [23] |
Trobaugh-Lotrario AD, Meyers RL, Tiao GM, et al. Pediatric liver transplantation for hepatoblastoma[J]. Transl Gastroenterol Hepatol, 2016, 1: 44.DOI: 10.21037/tgh.2016.04.01.
|
| [24] |
de Ville de Goyet J, Meyers RL, Tiao GM, et al. Beyond the Milan criteria for liver transplantation in children with hepatic tumours[J]. Lancet Gastroenterol Hepatol, 2017, 2(6): 456-462.DOI: 10.1016/S2468-1253(17)30084-5.
|
| [25] |
Cheng EY, Busuttil RW. Liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: out of the unknown[J]. JAMA Surg, 2015, 150(12): 1158-1159.DOI: 10.1001/jamasurg.2015.1875.
|
| [26] |
Kasahara M, Ueda M, Haga H, et al. Living-donor liver transplantation for hepatoblastoma[J]. Am J Transplant, 2005, 5(9): 2229-2235.DOI: 10.1111/j.1600-6143.2005.01003.x.
|
| [27] |
|
| [28] |
El-Gendi A, Fadel S, El-Shafei M, et al. Avoiding liver transplantation in post-treatment extent of disease Ⅲ and Ⅳ hepatoblastoma[J]. Pediatr Int, 2018, 60(9): 862-868.DOI: 10.1111/ped.13634.
|
| [29] |
Fuchs J, Cavdar S, Blumenstock G, et al. POST-TEXT Ⅲ and Ⅳ hepatoblastoma: extended hepatic resection avoids liver transplantation in selected cases[J]. Ann Surg, 2017, 266(2): 318-323.DOI: 10.1097/SLA.0000000000001936.
|
| [30] |
Namgoong JM, Hwang S, Oh SH, et al. Living-donor liver transplantation with inferior vena Cava replacement in an infant recipient with advanced hepatoblastoma[J]. Ann Hepatobiliary Pancreat Surg, 2020, 24(1): 72-77.DOI: 10.14701/ahbps.2020.24.1.72.
|
| [31] |
Hort A, Karpelowsky J, Shun A, et al. Use of a donor iliac vein graft for reconstruction of the inferior vena Cava in liver transplantation for hepatoblastoma with caval extension[J]. Pediatr Transplant, 2019, 23(4): e13409.DOI: 10.1111/petr.13409.
|
| [32] |
|